Dihexa

Evidence: ★☆☆☆☆ · Status: Not Approved

In plain English

Reportedly builds new brain connections powerfully in animals via a growth-factor pathway. No human data — and growth-factor pathways always carry a tumour question.

How it works

Angiotensin-IV-derived peptide that potentiates hepatocyte growth factor (HGF) / c-Met (MET) signalling to drive synaptogenesis (new synapses) — extremely potent in rodent memory models.

Molecular target & official sources

MET / c-Met receptor (NCBI Gene) · Frontiers peptide review

Bottom line

Striking animal potency, zero human evidence, real theoretical risk.

Helps with: Build Muscle & Strength · Focus & Cognition

Stacks with

Shares a pathway — often paired with: EPO (Erythropoietin), Tesamorelin (Egrifta), Human Growth Hormone (Somatropin), Insulin (anabolic misuse).

Availability & where to buy

Not widely approved. Not approved for general sale in most markets (Singapore included). Grey-market only — dose, purity and legality uncertain.

How it works: the PI3K/Akt growth factor pathway →